N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide

C21H16Cl2FN3O2S — CID 2570175

IUPACN-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide
SMILESO=C(CSC1=N/C(=C/c2ccc(Cl)c(Cl)c2)C(=O)N1c1ccccc1F)NC1CC1
InChIInChI=1S/C21H16Cl2FN3O2S/c22-14-8-5-12(9-15(14)23)10-17-20(29)27(18-4-2-1-3-16(18)24)21(26-17)30-11-19(28)25-13-6-7-13/h1-5,8-10,13H,6-7,11H2,(H,25,28)/b17-10+
InChIKeyOTBIUHXPTQRVLF-LICLKQGHSA-N
MW464.35 g/mol
LogP4.89
Rot. Bonds5

About N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide

N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide (PubChem CID 2570175) has the molecular formula C21H16Cl2FN3O2S and a molecular weight of 464.35 g/mol. Its IUPAC name is N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide.

Molecular Properties

Compound NameN-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide
PubChem CID2570175
Molecular FormulaC21H16Cl2FN3O2S
Molecular Weight464.35 g/mol
Exact Mass463.03
IUPAC NameN-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide
SMILESO=C(CSC1=N/C(=C/c2ccc(Cl)c(Cl)c2)C(=O)N1c1ccccc1F)NC1CC1
InChIInChI=1S/C21H16Cl2FN3O2S/c22-14-8-5-12(9-15(14)23)10-17-20(29)27(18-4-2-1-3-16(18)24)21(26-17)30-11-19(28)25-13-6-7-13/h1-5,8-10,13H,6-7,11H2,(H,25,28)/b17-10+
InChIKeyOTBIUHXPTQRVLF-LICLKQGHSA-N
XLogP4.89
TPSA61.77 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms30
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500464.35
LogP ≤ 54.89
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide?
The IUPAC name of N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide (CID 2570175) is N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide.
What is the SMILES notation for N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide?
The canonical SMILES for N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide is O=C(CSC1=N/C(=C/c2ccc(Cl)c(Cl)c2)C(=O)N1c1ccccc1F)NC1CC1.
What is the InChIKey of N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide?
The InChIKey is OTBIUHXPTQRVLF-LICLKQGHSA-N. The full InChI is InChI=1S/C21H16Cl2FN3O2S/c22-14-8-5-12(9-15(14)23)10-17-20(29)27(18-4-2-1-3-16(18)24)21(26-17)30-11-19(28)25-13-6-7-13/h1-5,8-10,13H,6-7,11H2,(H,25,28)/b17-10+.
What are the key properties of N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide?
N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide has a molecular weight of 464.35 g/mol, XLogP of 4.89, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopropyl-2-[(4E)-4-[(3,4-dichlorophenyl)methylidene]-1-(2-fluorophenyl)-5-oxoimidazol-2-yl]sulfanylacetamide is sourced from PubChem (CID 2570175), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).